Quantcast

J&J wins $1.67 billion verdict (access required)

By: Aaron Krivitzky
Published: July 13, 2009

Tags:

A unit of drugmaker Johnson & Johnson says a federal jury has returned a $1.67 billion verdict against Abbott Laboratories in a patent infringement suit over the companies' rheumatoid arthritis drugs. Abbott's best-selling drug, Humira, competes with the drug Remicade, made by Centocor, a unit of New Brunswick, N.J.-based J&J. Centocor and New York University ...
© Copyright 2012 Lawyers USA. All Rights Reserved.


POST A COMMENT

Sign-up for alerts

SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?

If not, click here to register and learn more now.


FEATURED PODCAST

Baby Boomer lawyers and retirement

Nelson Schwartz from The New York Times recently wrote an article titled, "Easing Out the Gray-Haired. Or Not.," spotlighting the fate of the Baby Boomer generation within law firms. Attorney and co-host Bob Ambrogi welcomes Attorney Valerie C. Samuels, a partner in the firm Posternak Blankstein & Lund LLP and co-chair of the Employment Law Group, and Attorney Roy Ginsburg, to take a look at this generation of baby boomers within law firms, retirement, their fate within the firm, options upon retirement and what this means for law firms: big, small and solo.

Click here to listen to the podcast.

Click here to download the podcast.

Click here for the Podcast archive.